Hepatocyte growth factor accelerates thrombopoiesis in transgenic mice

Laboratory Investigation

Volumn 87, Issue 3, 2007, Pages 284-291

  Kosone, Takashi ^a   Takagi, Hitoshi ^a   Horiguchi, Norio ^a   Toyoda, Mitsuo ^a   Sohara, Naondo ^a   Kakizaki, Satoru ^a   Sato, Ken ^a   Nishiyama, Uichi ^b   Kuwaki, Tomoaki ^b   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY   (Japan)

^b KIRIN BREWERY CO LTD   (Japan)

Author keywords

c Mpl; Ets; GABP; Hepatocyte growth factor; Thrombopoietin

Indexed keywords

GA BINDING PROTEIN; MESSENGER RNA; METALLOTHIONEIN; SCATTER FACTOR; THROMBOPOIETIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; GENE OVEREXPRESSION; HEMATOPOIETIC STEM CELL; HEP 2 CELL; HUMAN; HUMAN CELL; LIVER CELL CULTURE; LIVER REGENERATION; NUCLEOTIDE SEQUENCE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT; THROMBOCYTOPOIESIS; THROMBOCYTOSIS; TRANSGENIC MOUSE;

ANIMALS; BODY WEIGHT; CELL LINE, TUMOR; HEPATOCYTE GROWTH FACTOR; HUMANS; MICE; MICE, TRANSGENIC; ORGAN SIZE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; THROMBOPOIESIS; THROMBOPOIETIN;

EID: 33847642205     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.3700514     Document Type: Article

References (50)

1. Gohda E, Tsubouchi H, Nakayama H, et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988;81:414-419.
2. Nakamura T, Nishizawa T, Hagiya M, et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989;342:440-443.
3. Brinkmann V, Foroutan H, Sachs M, et al. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol 1995;131:1573-1586.
4. Zarnegar R, Michalopoulos GK. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 1995;129:1177-1180.
5. Galimi F, Bagnara GP, Bonsi L, et al. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors. J Cell Biol 1994;127:1743-1754.
6. Nishino T, Hisha H, Nishino N, et al. Hepatocyte growth factor as a hematopoietic regulator. Blood 1995;85:3093-3100.
7. Kuroiwa T, Kakishita E, Hamano T, et al. Hepatocyte growth factor ameliorates acute graft-versus-host disease and promotes hematopoietic function. J Clin Invest 2001;107:1365-1373.
8. Koibuchi N, Kaneda Y, Taniyama Y, et al. Essential role of HGF (hepatocyte growth factor) in blood formation in Xenopus. Blood 2004;103:3320-3325.
9. Uehara Y, Minowa O, Mori C, et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995;373:702-705.
10. Bladt F, Riethmacher D, Isenmann S, et al. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995;376:768-771.
11. Schmidt C, Bladt F, Goedecke S, et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995;373:699-702.
12. Hino M, Nishizawa Y, Tagawa S, et al. Constitutive expression of the thrombopoietin gene in a human hepatoma cell line. Biochem Biophys Res Commun 1995;217:475-481.
13. Ishikawa T, Ichida T, Matsuda Y, et al. Expression of hepatic thrombopoietin mRNA in primary cultured hepatocytes and in rats with acute liver injury or bone marrow suppression with or without cirrhosis. J Gastroenterol Hepatol 2000;15:647-653.
14. Yamashita K, Matsuoka H, Ochiai T, et al. Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers. J Gastroenterol Hepatol 2000;15:83-90.
15. Kaushansky K, Lok S, Holly RD, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994;369:568-571.
16. Shimada Y, Kato T, Ogami K, et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995;23:1388-1396.
17. de Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
18. Bartley TD, Bogenberger J, Hunt P, et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
19. Sohma Y, Akahori H, Seki N, et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994;353:57-61.
20. Broudy VC, Lin NL, Sabath DF, et al. Human platelets display high-affinity receptors for thrombopoietin. Blood 1997;89:1896-1904.
21. Fielder PJ, Hass P, Nagel M, et al. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 1997;89:2782-2788.
22. Kuwaki T, Hagiwara T, Yuki C, et al. Quantitative analysis of thrombopoietin receptors on human megakaryocytes. FEBS Lett 1998;427:46-50.
23. Fielder PJ, Gurney AL, Stefanich E, et al. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 1996;87:2154-2161.
24. Stefanich E, Senn T, Widmer R, et al. Metabolism of thrombopoietin (TPO) in vivo: determination of the binding dynamics for TPO in mice. Blood 1997;89:4063-4070.
25. Kato T, Oda A, Inagaki Y, et al. Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. Proc Natl Acad Sci USA 1997;94:4669-4674.
26. Takayama H, La Rochelle WJ, Anver M, et al. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci USA 1996;93:5866-5871.
27. Mathews MB, Bernstein RM, Franza Jr BR, et al. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984;309:374-376.
28. Bravo R, Frank R, Blundell PA, et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987;326:515-517.
29. Nishiyama U, Morita H, Torii Y, et al. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro. Thromb Haemost 2001;85:152-159.
30. Kamura T, Handa H, Hamasaki N, et al. Characterization of the human thrombopoietin gene promoter. A possible role of an Ets transcription factor, E4TF1/GABP. J Biol Chem 1997;272:11361-11368.
31. Sakata H, Takayama H, Sharp R, et al. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ 1996;7:1513-1523.
32. Horiguchi N, Takayama H, Toyoda M, et al. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 2002;21:1791-1799.
33. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997;89:101-107.
34. Wolber EM, Dame C, Fahnenstich H, et al. Expression of the thrombopoietin gene in human fetal and neonatal tissues. Blood 1999;94:97-105.
35. Dame C, Sutor AH. Primary and secondary thrombocytosis in childhood. Br J Haematol 2005;129:165-177.
36. Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta 2003;327:1-23.
37. Banu N, Price DJ, London R, et al. Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor. J Immunol 1996;156:2933-2940.
38. Masunaga H, Fujise N, Yamashita Y, et al. Deleted form of hepatocyte growth factor (dHGF) increases the number of platelets in rats with liver cirrhosis. Liver 1997;17:192-197.
39. Aoki M, Morishita R, Taniyama Y, et al. Angiogenesis induced by hepatocyte growth factor in non-infarcted myocardium and infarcted myocardium: up-regulation of essential transcription factor for angiogenesis, ets. Gene Ther 2000;7:417-427.
40. Taniyama Y, Morishita R, Nakagami H, et al. Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters. Circulation 2000;102:246-252.
41. Paumelle R, Tulasne D, Kherrouche Z, et al. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 2002;21:2309-2319.
42. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999;5:226-230.
43. Kosai K, Matsumoto K, Nagata S, et al. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 1998;244:683-690.
44. Ishiki Y, Ohnishi H, Muto Y, et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992;16:1227-1235.
45. Fujiwara K, Nagoshi S, Ohno A, et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993;18:1443-1449.
46. Morishita R, Aoki M, Nakamura S, et al. Gene therapy for cardiovascular disease using hepatocyte growth factor. Ann NY Acad Sci 2000;902:369-376.
47. Takayama H, LaRochelle WJ, Sabnis SG, et al. Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest 1997;77:131-138.
48. Takayama H, Takagi H, Larochelle WJ, et al. Ulcerative proctitis, rectal prolapse, and intestinal pseudo-obstruction in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest 2001;81:297-305.
49. Takayama H, LaRochelle WJ, Sharp R, et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 1997;94:701-706.
50. Otsuka T, Takayama H, Sharp R, et al. c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 1998;58:5157-5167.